The Effect of Mid-urethral Sling on the Urethral Dynamic Shape and Motion

February 27, 2023 updated by: NorthShore University HealthSystem
The purpose of this prospective cohort study is to investigate the effect of sling on urethral dynamic shape and motion using static and dynamic pelvic floor ultrasound and additionally compare the findings among women with successful vs failed surgical outcome.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This study is designed as a prospective cohort study. Our hypothesis is that mid-urethral sling provides backstop for excessive "swing motion" of distal urethra and helps with urethral compression along its luminal axis.

Aim 1: Investigate the effect of mid-urethral sling on the urethral shape at rest and maximum Valsalva, in other words dynamic urethral shape.

Aim 2: Compare the effect of mid-urethral sling on urethral dynamic shape in women with successful surgical outcome (absence of stress urinary incontinence at 3 and 12 months after the surgery) and women with surgical failure (presence of stress urinary incontinence at 3 and 12 months after the surgery).

Study Type

Observational

Enrollment (Actual)

190

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Skokie, Illinois, United States, 60076
        • NorthShore University Healthsystem

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women over 18 years old with stress urinary incontinence interested in treatment with midurethral sling

Description

Inclusion Criteria:

  • stress urinary incontinence interested in treatment with mid-urethral sling
  • able to consent in english and come to post-operative and research visits

Exclusion Criteria:

  • contraindication to mid-urethral sling
  • detrusor overactivity > 40cm H2O
  • post-void residual > 150mL
  • Maximum urethral closure pressure < 40 cm H2O

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urethral Shape at 3 months
Time Frame: 3 months
Urethral shape measured by ultrasound
3 months
Urethral Motion at 3 months
Time Frame: 3 months
Urethral motion measured by ultrasound
3 months
Urethral Shape at 12 months
Time Frame: 12 months
Urethral shape measured by ultrasound
12 months
Urethral Motion at 12 months
Time Frame: 12 months
Urethral motion measured by ultrasound
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Joel D Winer, MD, NorthShore University Healthsystem
  • Study Chair: Ghazaleh Rostami Nia, MD, NorthShore University Healthsystem
  • Study Director: Henry Chill, MD, NorthShore University Healthsystem

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 11, 2012

Primary Completion (Actual)

May 12, 2021

Study Completion (Actual)

May 14, 2021

Study Registration Dates

First Submitted

April 7, 2021

First Submitted That Met QC Criteria

April 12, 2021

First Posted (Actual)

April 14, 2021

Study Record Updates

Last Update Posted (Actual)

March 1, 2023

Last Update Submitted That Met QC Criteria

February 27, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Urinary Incontinence

Clinical Trials on Mid-urethral sling

3
Subscribe